Literature DB >> 32401043

Conserved High Free Energy Sites in Human Coronavirus Spike Glycoprotein Backbones.

Robert C Penner1,2.   

Abstract

Methods previously developed by the author are applied to uncover several sites of interest in the spike glycoproteins of all known human coronaviruses (hCoVs), including SARS-CoV-2 that causes COVID-19. The sites comprise three-dimensional neighborhoods of peptides characterized by four key properties: (1) they pinpoint regions of high free energy in the backbone whose obstruction might interrupt function; (2) by their very definition, they occur rarely in the universe of all gene-encoded proteins that could obviate host response to compounds designed for their interference; (3) they are common to all known hCoV spikes, possibly retaining activity in light of inevitable viral mutation; and (4) they are exposed in the molecular surface of the glycoprotein. These peptides in SARS-CoV-2 are given by the triples of residues (131, 117, 134), (203, 227, 228), and (1058, 730, 731) in its spike.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; conserved high free energy sites; coronavirus; spike glycoprotein backbones

Mesh:

Substances:

Year:  2020        PMID: 32401043     DOI: 10.1089/cmb.2020.0193

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  3 in total

1.  Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein.

Authors:  B Robson
Journal:  Comput Biol Med       Date:  2020-11-21       Impact factor: 4.589

2.  Mutagenic Distinction between the Receptor-Binding and Fusion Subunits of the SARS-CoV-2 Spike Glycoprotein and Its Upshot.

Authors:  Robert Clark Penner
Journal:  Vaccines (Basel)       Date:  2021-12-20

Review 3.  Seasonal Coronaviruses and Other Neglected Respiratory Viruses: A Global Perspective and a Local Snapshot.

Authors:  Sunčanica Ljubin-Sternak; Tomislav Meštrović; Ivana Lukšić; Maja Mijač; Jasmina Vraneš
Journal:  Front Public Health       Date:  2021-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.